When a condition affects only a small number of people, it’s easy to assume rare disease research benefits only those directly affected. The data says otherwise.
About this series: Research, Explained is a blog series by Rare Genes Movement that translates peer-reviewed rare disease research into plain language… for families who are navigating a lot already and don’t have time to decode a medical journal.
The Numbers Behind Rare Disease
A recent review published in ACR Open Rheumatology lays out the scale of what we’re dealing with… and why continued research isn’t optional.
Researchers also estimate that 70 to 80% of rare diseases have a genetic cause, and about 75% begin in childhood… which is a big part of why Rare Genes Movement exists in the first place.
The Challenge of Diagnosis
For many families, one of the hardest parts of the journey is getting an answer. That five year average isn’t just a statistic… it’s years of repeated testing, uncertainty, misdiagnoses, and difficulty accessing the right care. Researchers argue that closing this gap requires specialized expertise, collaboration between institutions, and stronger connections between research and patient care.
What Research Actually Does
It develops better diagnostic tools.
Every new tool that shortens the diagnostic odyssey means less time spent in the unknown for families searching for answers.
It identifies disease causes and improves predictions about outcomes.
Understanding the “why” behind a condition helps families and care teams plan further ahead, with more confidence.
It creates new treatments where almost none exist today.
With 95% of rare diseases still lacking an approved treatment, this is the piece with the most ground left to cover.
It quietly helps far more than the rare disease community.
Studying rare genetic conditions has helped researchers better understand immune disorders, inflammatory disease, and other conditions that affect millions of people who were never told the word “rare.”
The Power of Collaboration
One of the strongest messages in this review… progress happens when patients, families, clinicians, researchers, advocacy organizations, and institutions work together. Rare disease research cannot succeed in isolation. It requires multidisciplinary care teams, data sharing, international collaboration, and real investment in research infrastructure.
Families are no longer viewed as passive participants in research. Increasingly, they’re recognized as essential partners in shaping priorities and driving progress.
The diagnostic tools, treatments, and support systems of tomorrow begin with the research being conducted today.
Why Rare Genes Movement Cares
At Rare Genes Movement, we believe meaningful progress happens when families, clinicians, researchers, educators, and advocates work together. Whether through direct family support, educational initiatives, community engagement, or future tools like RAREmap, we’re committed to helping bridge the gap between diagnosis and direction… while supporting the research that improves the rare disease experience for the families who come after us.
Key Takeaway
Rare diseases may be individually uncommon, but together they affect hundreds of millions of people worldwide. Continued investment in research, collaboration, and family-centered innovation is essential to improving diagnosis, treatment, and quality of life for the rare disease community.
Peer-Reviewed Source
Hedrich CM. Importance and Potential of Rare Disease Research in Pediatric Rheumatology and Beyond: Pushing Frontiers. ACR Open Rheumatology. 2024.
This post is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding diagnosis, treatment, or any medical decisions for yourself or your child.
